Open AccessOutcome of patients with recurrent/metastatic squamous cell head and neck cancer treated with platinum‑based chemotherapy with or without cetuximab in real‑world practice
Author(s) -
Tina Zupančič,
Branko Zakotnik,
Cvetka Grašič Kuhar
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2352
Subject(s) - cetuximab , medicine , chemotherapy , hazard ratio , oncology , regimen , head and neck cancer , tolerability , cancer , proportional hazards model , retrospective cohort study , fluorouracil , progression free survival , radiation therapy , colorectal cancer , confidence interval , adverse effect
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom